These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8889562)
1. [Analysis of site differences in voiding condition of elderly men-- comparison to results of mass screening for prostate diseases between the villages of Shimamaki-mura, Hokkaido and Satomi-Mura, Ibaraki]. Masumori N; Tsukamoto T; Tanaka Y; Kumamoto Y; Ishikawa S; Akaza H; Koiso K Hinyokika Kiyo; 1996 Aug; 42(8):557-61. PubMed ID: 8889562 [TBL] [Abstract][Full Text] [Related]
2. [Uroflowmetry of males over 50 years old--analysis of the mass examination of the prostate]. Takagi Y; Kumamoto Y; Yamaguchi Y; Yoshioka M; Yokoyama E; Hayashi K; Furuya S; Ogura H Hinyokika Kiyo; 1987 Sep; 33(9):1368-74. PubMed ID: 2449056 [TBL] [Abstract][Full Text] [Related]
3. [Mass screening of prostate in Shiribeshi area in Hokkaido--incidence and clinical symptoms of benign prostatic hypertrophy and prostatic carcinoma]. Umehara T; Kumamoto Y; Mikuma N; Yamaguchi Y; Tsukamoto T; Miura T; Watanabe H; Ooe H Hinyokika Kiyo; 1990 Apr; 36(4):415-23. PubMed ID: 1696062 [TBL] [Abstract][Full Text] [Related]
4. [A study on the mass screening system for prostatic diseases]. Sakamoto M; Katayama T; Umeda K; Kazama T; Terada T; Fuse H Hinyokika Kiyo; 1992 Aug; 38(8):907-11. PubMed ID: 1384293 [TBL] [Abstract][Full Text] [Related]
5. Signs and symptoms of benign prostatic hyperplasia in men screened for prostatic carcinoma. Bosch JL; Niemer AQ; Kirkels WJ; Schröder FH Prog Clin Biol Res; 1994; 386():97-107. PubMed ID: 7528432 [No Abstract] [Full Text] [Related]
6. [Prostate tumor and its diagnosis]. Yamanaka H Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121 [TBL] [Abstract][Full Text] [Related]
7. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men. Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352 [TBL] [Abstract][Full Text] [Related]
9. Lower urinary tract symptoms and risk of prostate cancer in Japanese men. Matsubara A; Yasumoto H; Teishima J; Seki M; Mita K; Hasegawa Y; Yoshino T; Kato M; Usui T Int J Urol; 2006 Aug; 13(8):1098-102. PubMed ID: 16903936 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during prostate health awareness campaign. Teh GC; Sahabudin RM; Lim TC; Chong WL; Woo S; Mohan M; Khairullah A; Abrams P Med J Malaysia; 2001 Jun; 56(2):186-95. PubMed ID: 11771079 [TBL] [Abstract][Full Text] [Related]
11. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score. Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930 [TBL] [Abstract][Full Text] [Related]
12. Mass screening for prostate cancer in Korea: a population based study. Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY; J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541 [TBL] [Abstract][Full Text] [Related]
13. [Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases]. Shimizu N; Yamanaka H; Ichinose Y; Saitou Y Hinyokika Kiyo; 1998 Mar; 44(3):155-8. PubMed ID: 9589875 [TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district. Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966 [TBL] [Abstract][Full Text] [Related]
15. [Mass screening for prostate cancer in Nagano]. Ishizuka O; Satoh T; Kobayashi S; Nishizawa O Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167 [TBL] [Abstract][Full Text] [Related]
16. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380 [TBL] [Abstract][Full Text] [Related]
17. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715 [TBL] [Abstract][Full Text] [Related]
18. First year of mass screening for prostatic cancer in Yaizu city. Kawabe K; Ishikawa A Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673 [TBL] [Abstract][Full Text] [Related]
19. [Prostatic examinations of mass groups and early detection of cancer of the prostate]. Katayama T Hinyokika Kiyo; 1987 Oct; 33(10):1547-9. PubMed ID: 3445842 [TBL] [Abstract][Full Text] [Related]
20. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume. Gomes CM; Nunes RV; Araújo RM; Sacomani CR; Trigo-Rocha FE; Bruschini H; Srougi M Urol Int; 2008; 81(2):129-34. PubMed ID: 18758208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]